{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06036836",
            "orgStudyIdInfo": {
                "id": "4280A-010"
            },
            "secondaryIdInfos": [
                {
                    "id": "MK-4280A-010",
                    "type": "OTHER",
                    "domain": "Merck"
                },
                {
                    "id": "2023-505022-34",
                    "type": "REGISTRY",
                    "domain": "EU CT"
                }
            ],
            "organization": {
                "fullName": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)",
            "officialTitle": "A Multicenter, Randomized, Double-Blind, Phase 2, Basket Study of MK-4280A, a Coformulation of Favezelimab (MK-4280) With Pembrolizumab (MK-3475) in Selected Solid Tumors (KeyForm-010)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-of-favezelimab-coformulated-with-pembrolizumab-mk-in-participants-with-selected-solid-tumors-mk"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-03-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-21",
            "studyFirstSubmitQcDate": "2023-09-07",
            "studyFirstPostDateStruct": {
                "date": "2023-09-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate pathological complete response (pCR) rate of coformulated favezelimab/pembrolizumab (MK-4280A) or pembrolizumab as assessed by blinded central pathology review (BICR) in participants with cutaneous squamous cell carcinoma (cSCC) \\[Cohort A\\] and to evaluate lenvatinib in combination with coformulated favezelimab/pembrolizumab or pembrolizumab with respect to objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as assessed by investigator in participants proficient in mismatch repair (pMMR) endometrial cancer (EC) \\[Cohort B\\]."
        },
        "conditionsModule": {
            "conditions": [
                "Solid Tumor",
                "Cutaneous Squamous Cell Carcinoma",
                "Endometrial Cancer"
            ],
            "keywords": [
                "Programmed Cell Death-1 (PD1, PD-1)",
                "Programmed Cell Death-2 (PD2, PD-2)",
                "Programmed Cell Death Receptor Ligand 1 (PDL1, PD-L1)",
                "Programmed Cell Death Receptor Ligand 2 (PDL2, PD-L2)",
                "Lymphocyte-Activation Gene 3 (LAG-3)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 160,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Favezelimab/Pembrolizumab",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive coformulated favezelimab/pembrolizumab (800 mg/200 mg) via an intravenous (IV) infusion every 3 weeks (Q3W) for 3 cycles in the neoadjuvant period and 14 cycles of adjuvant therapy. Each cycle is 21 days. Participants who do not complete all 3 neoadjuvant cycles should have additional cycles in the adjuvant period so that the total number of study intervention administrations is 17 treatment cycles.",
                    "interventionNames": [
                        "Biological: favezelimab/pembrolizumab"
                    ]
                },
                {
                    "label": "Pembrolizumab",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive 200 mg pembrolizumab via an IV infusion Q3W for 3 cycles in the neoadjuvant period and 14 cycles of adjuvant therapy. Each cycle is 21 days. Participants who do not complete all 3 neoadjuvant cycles should have additional cycles in the adjuvant period so that the total number of study intervention administrations is 17 treatment cycles.",
                    "interventionNames": [
                        "Biological: pembrolizumab"
                    ]
                },
                {
                    "label": "Favezelimab/Pembrolizumab + Lenvatinib (Cohort B)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive coformulated favezelimab/pembrolizumab (800 mg/200 mg) via IV infusion Q3W for up to 35 cycles (each cycle is 21 days) PLUS lenvatinib every day (QD) 20 mg orally until disease progression, unacceptable toxicity, or discontinuation criteria are met.",
                    "interventionNames": [
                        "Biological: favezelimab/pembrolizumab",
                        "Drug: lenvatinib"
                    ]
                },
                {
                    "label": "Pembrolizumab + Lenvatinib (Cohort B)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive 200 mg pembrolizumab via IV infusion Q3W for up to 35 cycles (each cycle is 21 days) PLUS lenvatinib QD 20 mg orally until disease progression, unacceptable toxicity, or discontinuation criteria are met.",
                    "interventionNames": [
                        "Biological: pembrolizumab",
                        "Drug: lenvatinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "favezelimab/pembrolizumab",
                    "description": "IV infusion",
                    "armGroupLabels": [
                        "Favezelimab/Pembrolizumab",
                        "Favezelimab/Pembrolizumab + Lenvatinib (Cohort B)"
                    ],
                    "otherNames": [
                        "MK-4280A"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "pembrolizumab",
                    "description": "IV infusion",
                    "armGroupLabels": [
                        "Pembrolizumab",
                        "Pembrolizumab + Lenvatinib (Cohort B)"
                    ],
                    "otherNames": [
                        "MK-3475",
                        "Keytruda\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "lenvatinib",
                    "description": "Oral administration of capsule",
                    "armGroupLabels": [
                        "Favezelimab/Pembrolizumab + Lenvatinib (Cohort B)",
                        "Pembrolizumab + Lenvatinib (Cohort B)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Pathological Complete Response (pCR) - Cohort A",
                    "description": "pCR is defined as complete absence of viable tumor in the surgical resection sample as assessed by central review of the pathology results. Number of Cohort A participants with pCR will be reported.",
                    "timeFrame": "Up to approximately 22 months"
                },
                {
                    "measure": "Objective Response Rate (ORR) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by Investigator - Cohort B",
                    "description": "The ORR is defined as the percentage of participants who have an OR per investigator assessment. The OR is defined as a Complete Response (CR: disappearance of all target lesions) or Partial Response (PR: at least a 30% decrease in the sum of diameters of target lesions) per Response Evaluation Criteria In Solid Tumors Version 1.1 (RECIST 1.1). The percentage of participants who experience CR or PR as assessed by Blinded Independent Central Review (BICR) will be presented.",
                    "timeFrame": "Up to approximately 21 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Overall Survival (OS) - All Cohorts",
                    "description": "OS is defined as the time from randomization to death from any cause.",
                    "timeFrame": "Up to approximately 41 months"
                },
                {
                    "measure": "Clinical Benefit Rate - Cohort A",
                    "description": "Clinical benefit rate is defined as the percentage of participants who have clinical benefit. Clinical benefit is defined as pCR in participants who undergo surgery or clinical complete response (cCR) \\[defined as residual tumor not visible on clinical exam or on imaging and a negative biopsy, if biopsy is available, in participants who decline surgery.",
                    "timeFrame": "Up to approximately 22 months"
                },
                {
                    "measure": "Event-Free Survival (EFS) - Cohort A",
                    "description": "EFS is defined as the time from randomization to first progression prior to surgical resection as assessed by investigator, inability to resect tumor, recurrence (postsurgical resection), or death from any cause, whichever occurs first.",
                    "timeFrame": "Up to approximately 41 months"
                },
                {
                    "measure": "Major Pathological Response (mPR) - Cohort A",
                    "description": "mPR is defined as \u226410% of viable tumor cells in the surgical resection sample as assessed by central review of the pathology results. The number of Cohort A participants with mPR will be reported.",
                    "timeFrame": "Up to approximately 22 months"
                },
                {
                    "measure": "ORR per RECIST 1.1 as assessed by Investigator - Cohort A",
                    "description": "The ORR is defined as the percentage of participants who have an OR per investigator assessment. The OR is defined as a Complete Response (CR: disappearance of all target lesions) or Partial Response (PR: at least a 30% decrease in the sum of diameters of target lesions) per Response Evaluation Criteria In Solid Tumors Version 1.1 (RECIST 1.1). The percentage of participants who experience CR or PR as assessed by Blinded Independent Central Review (BICR) will be presented.",
                    "timeFrame": "Up to approximately 22 months"
                },
                {
                    "measure": "Number of participants with an adverse event (AE) - Cohorts A and B",
                    "description": "An AE is defined as any unfavorable and unintended sign including an abnormal laboratory finding, symptom or disease associated with the use of a medical treatment or procedure, regardless of whether it is considered related to the medical treatment or procedure, that occurs during the course of the study. The number of participants who experience an AE will be reported.",
                    "timeFrame": "Up to approximately 41 months"
                },
                {
                    "measure": "Number of participants discontinuing from study therapy due to AE - Cohorts A and B",
                    "description": "An AE is defined as any unfavorable and unintended sign including an abnormal laboratory finding, symptom or disease associated with the use of a medical treatment or procedure, regardless of whether it is considered related to the medical treatment or procedure, that occurs during the course of the study. The number of participants who discontinue study treatment due to an AE will be reported.",
                    "timeFrame": "Up to approximately 41 months"
                },
                {
                    "measure": "Number of participants experiencing perioperative complications - Cohort A",
                    "description": "The number of participants who experience perioperative complications will be assessed.",
                    "timeFrame": "Up to approximately 18 weeks"
                },
                {
                    "measure": "Number of participants with an AE that precludes surgery/initiation of adjuvant therapy - Cohort A",
                    "description": "An AE is defined as any unfavorable and unintended sign including an abnormal laboratory finding, symptom or disease associated with the use of a medical treatment or procedure, regardless of whether it is considered related to the medical treatment or procedure, that occurs during the course of the study. The number of Cohort A participants with an AE that precludes surgery or initiation of adjuvant therapy will be reported.",
                    "timeFrame": "Up to approximately 2 months"
                },
                {
                    "measure": "Progression Free Survival (PFS) - Cohort B",
                    "description": "PFS is defined as the time from randomization to the first documented progressive disease (PD) or death due to any cause, whichever occurs first as assessed by the investigator. Per RECIST 1.1, or by histopathologic confirmation of disease progression (PD), PD is defined as \u226520% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of \u22655 mm. The appearance of one or more new lesions is also considered PD. Unequivocal progression of non-target lesions is also considered PD.",
                    "timeFrame": "Up to approximately 41 months"
                },
                {
                    "measure": "Duration of Response (DOR) - Cohort B",
                    "description": "DOR is defined as the time from first documented evidence of CR (disappearance of all target lesions) or PR (at least a 30% decrease in the sum of diameters of target lesions) until progressive disease (PD) or death. Per RECIST 1.1, PD is defined as at least a 20% increase in the sum of diameters of target lesions. In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. The appearance of one or more new lesions is also considered PD. DOR as assessed by Blinded Independent Central Review (BICR) will be presented.",
                    "timeFrame": "Up to approximately 41 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria\n\nCohort A only\n\n* Histologically confirmed diagnosis of resectable cutaneous squamous cell carcinoma (cSCC) as the primary site of malignancy (metastatic skin involvement from another primary cancer or from an unknown primary cancer is not permitted)\n* Stage II to Stage IV disease without distant metastasis (M1). cSCC tumors arising in the head and neck will be staged according to American Joint Committee on Cancer (AJCC) Edition (Ed.) 8 and cSCC tumors arising in non-head and neck locations will be staged according to Union for International Cancer Control (UICC) Ed. 8\n* Is systemic treatment na\u00efve\n* Archival tumor tissue sample, or newly obtained surgical resection, or biopsy sample of a tumor lesion not previously irradiated has been provided\n* Is an individual of any sex/gender, at least 18 years of age at the time of providing the informed consent\n\nCohort B only\n\n* Histologically confirmed diagnosis of endometrial cancer (EC) that is not deficient in mismatch repair (dMMR) proficient in mismatch repair (pMMR) as documented by a local test report\n* Documented evidence of stage IVB (per 2009 International Federation of Gynecology and Obstetrics (FIGO) staging), recurrent, or metastatic EC, and are not candidates for curative surgery or radiation\n* Has radiographic evidence of disease progression after 1 prior systemic, platinum-based chemotherapy regimen for EC in any setting\n* Measurable disease per Response Evaluation Criteria In Solid Tumors (RECIST 1.1) by investigator (before first dose of study intervention)\n* Is assigned female sex at birth, at least 18 years of age at the time of providing the informed consent\n* Has adequately controlled blood pressure without antihypertensive medication\n\nAll Cohorts\n\n* Agrees to follow contraception guidelines if a participant of childbearing potential\n* Has a life expectancy \\>3 years per investigator assessment\n* Has adequate organ function\n* Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n* If positive for hepatitis B, has received antiviral therapy for \u22654 weeks and undetectable viral load prior to randomization\n* If positive for hepatitis C, has undetectable viral load at screening\n* If positive for human immunodeficiency virus (HIV), has well-controlled HIV on a stable highly active antiretroviral therapy\n\nExclusion Criteria:\n\nAll Cohorts\n\n* Has known hypersensitivity to active substances or their excipients including previous clinically significant hypersensitivity reaction to treatment with other monoclonal antibody (mAb)\n* History of allogeneic tissue/solid organ transplant\n\nCohort A only\n\n* Received prior radiotherapy to the index lesion (in-field lesion)\n* Participants for whom the primary site of cSCC was anogenital area (penis, scrotum, vulva, perianal region) are not eligible\n\nCohort B\n\n* Has had major surgery within 3 weeks prior to first dose of study interventions\n* Has preexisting \u2265Grade 3 gastrointestinal or non-gastrointestinal fistula\n* Has urine protein \u22651 g/24 hours\n* Has a left ventricle ejection fraction (LVEF) below the institutional (or local laboratory) normal range, as determined by multi-gated acquisition (MUGA) or echocardiogram (ECHO)\n* Has radiographic evidence of encasement or invasion of a major blood vessel, or of intratumoral cavitation\n* Has clinically significant cardiovascular disease within 12 months from first dose of study intervention",
            "healthyVolunteers": false,
            "sex": "ALL",
            "genderBased": true,
            "genderDescription": "Cohort A Only - Participant is an individual of any sex/gender\n\nCohort B Only - Participant is assigned female sex at birth",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Toll Free Number",
                    "role": "CONTACT",
                    "phone": "1-888-577-8839",
                    "email": "Trialsites@merck.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Merck Sharp & Dohme LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Yale-New Haven Hospital-Yale Cancer Center ( Site 0643)",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06510",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "203-785-4095"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Dana-Farber Cancer Institute ( Site 0642)",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "617-632-3000"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Rutgers Cancer Institute of New Jersey ( Site 0635)",
                    "status": "RECRUITING",
                    "city": "New Brunswick",
                    "state": "New Jersey",
                    "zip": "08903",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "732-235-2465"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.48622,
                        "lon": -74.45182
                    }
                },
                {
                    "facility": "Duke Cancer Institute ( Site 0641)",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "888-275-3853"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Cleveland Clinic Main ( Site 0639)",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "800-223-2273"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "St. Luke's University Health Network ( Site 0636)",
                    "status": "RECRUITING",
                    "city": "Bethlehem",
                    "state": "Pennsylvania",
                    "zip": "18015",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "866-785-8537"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.62593,
                        "lon": -75.37046
                    }
                },
                {
                    "facility": "UPMC Hillman Cancer Center ( Site 0644)",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "412-647-2811"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "UT Southwestern Medical Center-CRO-Simmons Comprehensive Cancer Center ( Site 0645)",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390-9179",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "214-645-0595"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "St Vincent's Hospital-The Kinghorn Cancer Centre ( Site 0005)",
                    "status": "RECRUITING",
                    "city": "Darlinghurst",
                    "state": "New South Wales",
                    "zip": "2010",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0405536859"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.87939,
                        "lon": 151.21925
                    }
                },
                {
                    "facility": "Royal North Shore Hospital ( Site 0008)",
                    "status": "RECRUITING",
                    "city": "St Leonards",
                    "state": "New South Wales",
                    "zip": "2065",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+61433333445"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.82344,
                        "lon": 151.19836
                    }
                },
                {
                    "facility": "Blacktown Hospital ( Site 0003)",
                    "status": "RECRUITING",
                    "city": "Sydney",
                    "state": "New South Wales",
                    "zip": "2148",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "61298455200"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.86785,
                        "lon": 151.20732
                    }
                },
                {
                    "facility": "Royal Brisbane and Women's Hospital ( Site 0002)",
                    "status": "RECRUITING",
                    "city": "Brisbane",
                    "state": "Queensland",
                    "zip": "4029",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "61402240196"
                        }
                    ],
                    "geoPoint": {
                        "lat": -27.46794,
                        "lon": 153.02809
                    }
                },
                {
                    "facility": "The Alfred Hospital ( Site 0004)",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "state": "Victoria",
                    "zip": "3004",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "61390763129"
                        }
                    ],
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Fiona Stanley Hospital ( Site 0006)",
                    "status": "RECRUITING",
                    "city": "Murdock",
                    "state": "Western Australia",
                    "zip": "6150",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "61861522222"
                        }
                    ]
                },
                {
                    "facility": "Sunnybrook Research Institute ( Site 0607)",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M4N 3M5",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "(416) 480-4928"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Princess Margaret Cancer Centre ( Site 0606)",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 2M9",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "4169464501"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Jewish General Hospital ( Site 0605)",
                    "status": "RECRUITING",
                    "city": "Montreal",
                    "state": "Quebec",
                    "zip": "H3T 1E2",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "15147123215"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al ( Site 0602)",
                    "status": "RECRUITING",
                    "city": "Montr\u00e9al",
                    "state": "Quebec",
                    "zip": "H2X 3E4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "514-890-8000"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "McGill University Health Centre ( Site 0604)",
                    "status": "RECRUITING",
                    "city": "Montr\u00e9al",
                    "state": "Quebec",
                    "zip": "H4A 3J1",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "5145772241"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Centre int\u00e9gr\u00e9 de canc\u00e9rologie du CHU de Qu\u00e9bec Universit\u00e9 Laval, H\u00f4pital de l'Enfant-J\u00e9sus ( Site 0",
                    "status": "RECRUITING",
                    "city": "Quebec City",
                    "state": "Quebec",
                    "zip": "G1J 1Z4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "15147123215"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                },
                {
                    "facility": "Institut de canc\u00e9rologie Strasbourg Europe (ICANS) ( Site 0153)",
                    "status": "RECRUITING",
                    "city": "Strasbourg",
                    "state": "Alsace",
                    "zip": "67200",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "33368767204"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.58392,
                        "lon": 7.74553
                    }
                },
                {
                    "facility": "Centre Hospitalier R\u00e9gional Universitaire de Brest - H\u00f4pital Morvan ( Site 0154)",
                    "status": "RECRUITING",
                    "city": "Brest",
                    "state": "Finistere",
                    "zip": "29200",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "33298223985"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.3903,
                        "lon": -4.48628
                    }
                },
                {
                    "facility": "CENTRE LEON BERARD ( Site 0151)",
                    "status": "RECRUITING",
                    "city": "Lyon Cedex08",
                    "state": "Rhone-Alpes",
                    "zip": "69373",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+33478782888"
                        }
                    ]
                },
                {
                    "facility": "Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 0155)",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75014",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+3358411765"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Universitaetsklinikum Essen ( Site 0185)",
                    "status": "RECRUITING",
                    "city": "Essen",
                    "state": "Nordrhein-Westfalen",
                    "zip": "45147",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0201 723 85647"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.45657,
                        "lon": 7.01228
                    }
                },
                {
                    "facility": "Universitaetsklinikum Essen-Klinik f\u00fcr Dermatologie, Venerologie und Allergologie ( Site 0182)",
                    "status": "RECRUITING",
                    "city": "Essen",
                    "state": "Nordrhein-Westfalen",
                    "zip": "45147",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "492017232431"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.45657,
                        "lon": 7.01228
                    }
                },
                {
                    "facility": "Fondazione IRCCS Istituto Nazionale dei Tumori-SC Oncologia Medica 3 - Tumori Testa-collo ( Site 025",
                    "status": "RECRUITING",
                    "city": "Milan",
                    "state": "Lombardia",
                    "zip": "20133",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0039 0223903352"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Istituto Nazionale Tumori IRCCS Fondazione Pascale-s.c. melanoma, immunoterapia oncologica e terapi",
                    "status": "RECRUITING",
                    "city": "Napoli",
                    "zip": "80131",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "390815903431"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Hospital Sultan Ismail-Pusat Rawatan Radioterapi Dan Onkologi ( Site 0063)",
                    "status": "RECRUITING",
                    "city": "Johor Bahru",
                    "state": "Johor",
                    "zip": "81100",
                    "country": "Malaysia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "60107661015"
                        }
                    ],
                    "geoPoint": {
                        "lat": 1.4655,
                        "lon": 103.7578
                    }
                },
                {
                    "facility": "University Malaya Medical Centre ( Site 0061)",
                    "status": "RECRUITING",
                    "city": "Lembah Pantai",
                    "state": "Kuala Lumpur",
                    "zip": "59100",
                    "country": "Malaysia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "60379492120"
                        }
                    ]
                },
                {
                    "facility": "Sarawak General Hospital-Radiotherapy Unit ( Site 0062)",
                    "status": "RECRUITING",
                    "city": "Kuching",
                    "state": "Sarawak",
                    "zip": "93586",
                    "country": "Malaysia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+6082-276666 Ext6036"
                        }
                    ],
                    "geoPoint": {
                        "lat": 1.54999,
                        "lon": 110.33333
                    }
                },
                {
                    "facility": "Radboudumc ( Site 0274)",
                    "status": "RECRUITING",
                    "city": "Nijmegen",
                    "state": "Gelderland",
                    "zip": "6525 GA",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "31243615025"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.8425,
                        "lon": 5.85278
                    }
                },
                {
                    "facility": "Erasmus Medisch Centrum ( Site 0272)",
                    "status": "RECRUITING",
                    "city": "Rotterdam",
                    "state": "Zuid-Holland",
                    "zip": "3015 GD",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "31107041754"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.9225,
                        "lon": 4.47917
                    }
                },
                {
                    "facility": "University Medical Center Groningen ( Site 0273)",
                    "status": "RECRUITING",
                    "city": "Groningen",
                    "zip": "9700RB",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "31503616161"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.21917,
                        "lon": 6.56667
                    }
                },
                {
                    "facility": "Taichung Veterans General Hospital-GYNECOLOGY ( Site 0033)",
                    "status": "RECRUITING",
                    "city": "Taichung",
                    "zip": "407",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "886-4-2359-2525 ext.5822"
                        }
                    ],
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "National Cheng Kung University Hospital-Clinical Trial Center ( Site 0032)",
                    "status": "RECRUITING",
                    "city": "Tainan",
                    "zip": "704",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "886623535354559"
                        }
                    ],
                    "geoPoint": {
                        "lat": 22.99083,
                        "lon": 120.21333
                    }
                },
                {
                    "facility": "National Taiwan University Hospital ( Site 0031)",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "10002",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "886223123456"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Medipol Mega Universite Hastanesi-oncology ( Site 0425)",
                    "status": "RECRUITING",
                    "city": "Stanbul",
                    "state": "Istanbul",
                    "zip": "34214",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905325280486"
                        }
                    ]
                },
                {
                    "facility": "Gulhane Egitim Arastirma Hastanesi-Onkoloji ( Site 0424)",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06010",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905366401020"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Hacettepe Universite Hastaneleri-oncology hospital ( Site 0421)",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06230",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905326880089"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Liv Hospital Ankara-Oncology ( Site 0426)",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06680",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905056604536"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Ankara Bilkent \u015eehir Hastanesi ( Site 0427)",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06800",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "905052933234"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 0423)",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34722",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "00905063509061"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Merck Clinical Trials Information",
                    "url": "http://www.merckclinicaltrials.com"
                },
                {
                    "label": "Plain Language Summary",
                    "url": "https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=4280A-010&kw=4280A-010"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf",
            "url": "http://engagezone.msd.com/ds_documentation.php"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M6845",
                    "name": "Death",
                    "relevance": "LOW"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                },
                {
                    "id": "C000531958",
                    "term": "Lenvatinib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M353738",
                    "name": "Lenvatinib",
                    "asFound": "Approved",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}